throbber
J. CHEM. SOC. PERKIN TRANS. I 1994
`
`211
`
`Synthesis of 3' -O-(w-Aminoalkoxymethyl)thymidine 5'-Triphosphates,
`Terminators of DNA Synthesis that Enable 3' -Labelling
`
`Jari Hovinen, *,a,b Elena Azhayeva,a,c Alex Azhayev,a,c Andrei Guzaev 8 and
`Harri Lonnberg a
`a University of Turku, Department of Chemistry, FIN-20 500 Turku, Finland
`6 Turku Centre for Biotechnology, BioCity, FIN-20 520 Turku, Finland
`c Joint Biotechnology Laboratory, BioCity, FIN-20 520 Turku, Finland
`
`Treatment of 5' -0-benzoylthymidine 1 with a mixture of acetic anhydride, acetic acid and dimethyl
`sulfoxide yielded 5'-0-benzoyl-3'-0-methylthiomethylthymidine 2. which was converted via the 3'-
`0-bromomethyl derivative into 3' -0-(ro-aminoalkoxymethyl)thymidines 7 bearing a 6, 8 or 10
`methylene groups long hydrocarbon chain, and finally to their 5' -triphosphates 10. The latter
`compounds were shown to be terminators of DNA synthesis catalysed by thermostable Tet/z DNA(cid:173)
`polymerase. and may be labelled at the aliphatic amino group with fluorescent probes.
`
`Quite m.:ently a rapid solid-phase method, called mini(cid:173)
`sequencing, has been introduced for the detection of point
`mutation of DNA. 1•2 The method involves hybridization of
`immobilized single-stranded DNA with a primer that ends
`immediately before the site of mutation, and elongation of the
`chain with a single labelled deoxyribonucleoside 5' -triphos(cid:173)
`phate. Parallel runs with each of the four possible nucleotides
`enable identification of the mutated base. Thus far only
`radiochemically labelled nucleotides have been used. Applic(cid:173)
`ation of nonradioactive techniques, such as fluorescence
`detection, is hampered by the fact that the nucleoside tri(cid:173)
`phosphates bearing the fluorescent probe should be reasonably
`good substrates of DNA polymerase. As a first step in our
`efforts to find a common labelling strategy for all the nucleotides
`occurring in DNA, we now report on the preparation of some
`thymidine 5' -triphosphates bearing a long chain aminoalkoxy(cid:173)
`methyl side arm at 3' -0. Their ability to serve as specific
`terminators of DNA synthesis catalysed by DNA polymerases
`were studied before and after attachment of fluorescent probes
`to their amino function.
`
`Results and Discussion
`The reaction sequence utilized in the preparation of 3'-O-(co(cid:173)
`aminoalkoxymethyl)thymidine 5'-triphosphates is depicted in
`Scheme 1. The key steps are discussed below.
`
`Formation of the Methylthiomethyl Ether 2.~Methylthio(cid:173)
`methyl ethers are well-known by-products of the oxidation of
`alcohols with a mixture of acetic anhydride and dimethyl
`sulfoxide (DMSO). 3- 8 The amount of these by-products has
`been shown to vary from traces to more than 70% depending on
`the nature of the alcohol. Addition of acetic acid to the reaction
`mixture markedly increases the yield of the methylthiomethyl
`ether. 9 This observation was exploited in the preparation of 3' -
`O-methylthiomethylthymidine. Treatment of 5'-O-benzoyl(cid:173)
`thymidine 10 I with a mixture of DMSO, acetic acid and acetic
`anhydride (54: 11: 35. v /v) for 2 days at ambient temperature
`gave, after purification, an almost 70% yield of the desired
`3'-O-methylthiomethyl derivative 2.
`
`Attachment of the Aliphatic Arm to 03' 3.~The methyl(cid:173)
`thiomethyl ether, 2, was first converted into the more reactive
`bromomethyl ether, 11 14 by
`treating 2 with N-bromo(cid:173)
`succinimide (NBS) or molecular bromine in dry dichloroethane.
`When the 5'-O-benzoyl-3' -O-bromomethylthymidine obtained
`
`was allowed to react in situ with a long-chain co-bromo alcohol
`(6 to 10 carbons), in the presence of 2,6-lutidine (2,6-di(cid:173)
`methylpyridine),
`the corresponding 3' -O-(w-bromoalkoxy(cid:173)
`methyl)thymidines, 3a--c, were formed. The same methodology
`has successfully been used also with appropriately protected
`guanosine, cytidine and adenosine analogues without severe
`side reactions. 9 It has been shown that when N-iodosuccinimide
`(NIS) is used as the halogen source in a large excess (sixfold),
`the main product is the corresponding succinimide derivative,
`3d. 12• 13 In the present synthesis only traces of this kind of
`side product were found, and the formation of the side product
`was completely prevented by using molecular bromide as a
`thiophilic promoter instead of N-halogenosuccinimide. How(cid:173)
`ever, a small amount ( ~ 10%) of another, slow-migrating side
`product was formed (Rr 0.29 compared to 0.37 of 3a; MeOH(cid:173)
`CH2Cl2, 3: 97, v/v). The product had an identical UV spectrum
`with the main product, and its 1 H N MR spectrum exhibited
`double signals for H6 and sugar protons, but only single peaks
`for the aliphatic arm and a singlet (2 H) at i5 5.47 probably
`referring to NCH 2O. After deprotection with methanolic
`ammonia, the 13C NMR showed four signals in the carbonyl
`carbon region of the thymidine residue. Accordingly, the side
`product may tentatively be assigned as a dimer 3e containing a
`methylene bridge between 03' of one thymidine and N3 of the
`other.
`The w-bromo substituent was displaced by azide ion by
`heating 3a--c in a mixture of sodium azide and lithium chloride
`in dimethylformamide (DMF). The reaction mixture was
`'buffered' with ammonium chloride to prevent the cleavage of
`the base labile 5'-O-benzoyl group. The displacement was
`almost quantitative. After conventional work up, the product,
`4a--c, was purified by silica gel column chromatography. The
`overall yield starting from 2 was normally about 50%.
`The original idea was to debenzoylate 4a--c, phosphorylate
`the deblocked 5'-OH (5a--c) and then reduce the azido group
`to an amino function. Unfortunately, the reduction of azido
`to amino with triphenylphosphine in a mixture of aqueous
`ammonia and dioxane failed, when applied to triphosphates,
`although the corresponding azido nucleosides Sa--c were
`rapidly reduced with an excess of triphenylphosphine in
`pyridine. It has also been reported that 3'-azido-3'-deoxythy(cid:173)
`midine 5'-triphosphate can easily be reduced to the 3'-amino
`analogue by the method described above. 15
`Since the azido group was reduced at nucleoside level, the
`resulting amino function has to be protected before phosphoryl(cid:173)
`ation of 5' -OH. This was done by treating the aminoalkoxy-
`
`Illumina Ex. 1060
`IPR Petition - USP 10,435,742
`
`

`

`212
`
`J. CHEM. SOC. PERKIN TRANS. I 1994
`
`Ill
`
`BzO?
`
`OCH20(CH2)n Br
`3a-c
`n=6,8or10
`
`0
`0
`0
`II
`II
`II
`-0-)-0-)-0-)-ovo✓
`o-
`o-
`o- ~
`
`OCH20(CH2ln Na
`
`HO?
`
`v
`
`BzO?
`
`OCH20(CH2ln Na
`Sa-c
`
`OCH20(CH2ln Na
`4a-c
`
`HO?
`
`~
`
`HOvO✓
`~ viii
`
`OCH20(CH2ln NH2
`7a-c
`
`OCH20(CH2ln NHCOCFa
`8a-c
`
`0
`0
`0
`II
`II
`II
`-o-)-0-f-0-)-ovo✓
`o-
`o-
`o- ~
`
`OCH20(CH2ln NHCOCFa
`
`X
`
`0
`0
`0
`II
`II
`II
`-o-P-O-P-0-P-O?
`I
`I
`I
`0
`o-
`o-
`o-
`
`OCH20(CH2)n NH2
`
`10a-c
`
`11
`
`OH
`
`Scheme 1 Reagents and conditions: i, AcOH-Ac2O, DMSO; ii, NBS or Br 2, CICH2CH2CI; iii, Br(CH2).OH, lutidine; iv, N 3 - , DMF;
`v, NH 3-MeOH; vi, (a) Ph3P, pyridine (b) NH 3 (aq.); vii, CF3CO2Me, DMF; viii, (a) PO(triazoleh-MeCN (b) P2O 7-DMF (c) H 2O; ix, NH 3(aq.);
`x, FITC,pH JO
`
`BzO?
`
`0 ~ft
`e,o?)
`
`OCH20(CH2l6Br
`3e
`
`3d
`
`methyl nucleosides 7a--c with an excess of methyl trifluoro(cid:173)
`acetate in dry DMF. When the ester was dry and freshly
`distilled, the reaction was quantitative and the product 8a--c
`was easily isolated on a short silica gel column.
`
`Synthesis of 5'-Triphosphates.-A modification of the
`method of Otvos et al. 16 was applied to the preparation of the
`nucleoside 5' -triphosphates, 9a--c. According to the original
`method, the nucleoside is allowed to react with phosphorus
`oxychloride in dry trimethyl phosphate, and the intermediate
`formed is treated in situ with bis(tributylammonium) pyro-
`
`phosphate. Unfortunately, phosphorylation of the nucleoside
`with POC13 requires a prolonged treatment, and hence the
`hydrogen chloride liberated may cleave the acetal linkage in
`8a--c. To avoid this, a slightly different approach was applied.
`The nucleoside was first treated with phosphoryltris(triazole)
`in dry acetonitrile 1 7 and the intermediate obtained was allowed
`to react overnight with bis(tributylammonium) pyrophosphate.
`The remaining triazole ligand was hydrolysed by addition of
`water to give 9a--c. Treatment of 9a--c with aqueous ammonia
`gave lOa--c as the final products.
`In order to demonstrate the usefulness of 3'-0-(co-amino(cid:173)
`alkoxymethyl)thymidine 5' -triphosphates prepared as sub(cid:173)
`strates of DNA polymerases even when attached to bulky
`fluorescent groups, 10a was labelled with fluorescein isothio(cid:173)
`cyanate. The reaction was quantitative and the product, 11,
`was purified by HPLC.
`
`Termination of DNA Synthesis Catalysed by Thermostable
`Tet/z-DNA Polymerase.-Compounds lOa--cdiffersignificantly
`from the well-known terminators of DNA synthesis, such as
`2',3' -dideoxyribonucleoside 5' -triphosphates 18 and 3' -amino-
`2',3' -dideoxyribonucleoside 5' -triphosphates. 19 Their co-amino(cid:173)
`alkoxymethyl side arms enable attachment of reporter groups,
`either before or after enzymatic incorporation into DNA, and
`hence labelling of the 3'-terminus of DNA. The potential
`advantages of the usage of a long flexible acetal arm were
`
`

`

`J. CHEM. SOC. PERKIN TRANS. I 1994
`
`expected to be (i) the reporter groups may be kept distant from
`the catalytic centre of the polymerase enzymes, and (ii) the
`flexible arm would not severely restrict the conformational
`motion that the sugar ring undergoes on binding to enzyme.
`Indeed, compounds IOa--c, as well as their analogues bearing a
`trifluoroacetyl 9a--c or fluorescein group 11, at the amino
`function were observed to be specific terminators of DNA
`synthesis catalysed by thermostable polymerases.* Fig. I shows
`the results obtained with Tet/z DNA-polymerase, using 2',3'(cid:173)
`dideoxyribonucleoside 5'-triphosphates and compounds 9a,
`toa--c and 11 as terminators. It is clearly seen that 3' -O-(w(cid:173)
`aminoalkoxymethyl)thymidine 5' -triphosphates IOa--c as well
`as their analogues, 9a and 11, terminate DNA synthesis, giving
`patterns very similar to that of 2',3'-dideoxythymidine 5'-tri(cid:173)
`phosphate.
`
`Experimental
`All the solvents used were of analytical grade and were distilled
`and dried before use. Thymidine was purchased from Sigma
`and w-bromo alcohols and fluorescein isothiocyanate from
`Aldrich. Adsorption column chromatography was performed
`on columns of silica gel 60 (Merck), and triphosphates were
`purified on Fractogel TSK DEAE-640(M) (Merck). TLC was
`conducted on silica-60 F 254 plates (Merck). The melting points
`reported are uncorrected. NMR spectra were recorded on a
`JEOL JNM GX-400 spectrometer operating at 399.8, 100.5 and
`161.9 MHz for 1H, 13C and 31P, respectively. Coupling
`constants are given in Hz. Tetramethylsilane was used as
`internal (1H, 13C) and H 3PO4 as external reference (3 1P). 13C
`NMR data of the compounds prepared are listed in Table I. IR
`spectra were recorded on Perkin-Elmer I 600 FT-IR spectro(cid:173)
`photometer and UV spectra on Perkin-Elmer A-2 spectro(cid:173)
`photometer. Elemental analyses were performed by Analytische
`Laboratorien, Germany, or at Department of Chemistry,
`University of Oulu, Finland. Tet/z DNA-polymerase from
`Thermus thermophilus was generously supplied by Dr. V.
`Kiselev (Research Center of Molecular Diagnostics and
`Therapy, Moscow, Russia). 2'-Deoxyadenosine 5'-[a:- 35S]tri(cid:173)
`phosphate (initial specific activity 1300 Ci mmoJ- 1) was
`obtained from NEN. 2' -Deoxy-and 2' ,3' -dideoxy-ribonucleo(cid:173)
`side 5'-triphosphates were from Pharmacia, and control single
`stranded M 13 mp 18 DNA from USB.
`
`2.- Com-
`5' -0-Benzoyl-3' -0-methylthiomethylthymidine
`pound 1 10 (15.0 g, 43.3 mmol) was dissolved in DMSO (145
`cm 3 ) and acetic acid (29 crn 3 ) and acetic anhydride (93 cm 3 )
`were added . The mixture was stirred at room temperature for
`2 days, i. e. until no starting material was detected by TLC, and
`was then evaporated to give an oily residue. The oil was
`dissolved in methylene chloride ( 150 cm 3 ) and washed with sat.
`aq. NaHCO 3 (3 x 75 cm 3). The organic layer was dried
`(Na2SO4), filtered and evaporated to dryness. The resulting
`solid was purified on a silica gel column, using CH 2Cl 2
`containing from O to 2% MeOH as eluent. Pure fractions were
`combined and concentrated, and the residue was crystallized
`from toluene to give the title compound 2 (12.0 g, 68%) as a
`white powder; m.p. 135 °C; Rr 0.66 (silica gel, CH 2Cl 2- MeOH,
`9 : I, v/v); ).m • .(MeOH)/nm 266; 6H(CDCl 3) 8.68 (l H, br s,
`HJ), 8.04-7.48 (5 H, m, arom), 7.24 (I H, s, H6), 6.30 (l H, dd,
`Jl'2' 7.6,Jl'2'' 6,J,Hl'),4.69(2H,JAB I l.6,OCH2S),4.65(1 H,dd,
`J4._5 . 3.4, J 5 ,_ 5 • 12.2, HS'), 4.58 (l H, m, HJ'), 4.55 (I H, dd,
`J4._ 5 .. 4.0, HS"), 4.37 (l H, m, H4'), 2.16 (I H, ddd, J 2 •• 2 .. 13.8,
`Jr. 3 • 3.4, H2"), 2.16 (3 H, s, SCH 3 ) , 2.13 (I H, m, J 2 , _3 • 5.9,
`
`* These results will be published elsewhere.
`
`213
`
`T
`
`--
`
`-
`
`-
`
`---- - --
`
`-
`
`----
`------
`-----
`--
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`Fig. 1 Gel pattern of the DNA synthesis catalysed by a thermostable
`DNA-polymerase, Tet/z, and
`terminated with 2',3'-dideoxyribo(cid:173)
`nucleoside 5' -triphosphates (ddNTP) and various 3' -O-(ro-amino(cid:173)
`alkoxymethyl)thymidine 5'-triphosphates (9a, lOa-c and 11). Tracks
`1---4 show termination with ddGTP (7 µmol dm-3 ), ddATP (147 µmol
`dm- 3) , ddCTP (56 µmol dm-3 ) and ddTIP (86 µmol dm-3 ), respectively.
`Tracks 5- 9 show termination with 10a (455 µmol dm- 3 ), 10b (350 µmol
`dm-3 ) and Hie (210 µmol dm- 3) , 9a (455 µmol dm-3 ) and 11 (260 µmol
`dm-3), respectively.
`
`

`

`214
`
`J. CHEM. SOC. PERKIN TRANS. I 1994
`
`Table I
`
`13C NMR chemical shifts of the thymidine analogues prepared"
`
`Chemical shift
`
`Compound C2
`
`C4
`
`C5
`
`C6
`
`5-CH 3 Cl' C2' C3' C4' CS' Others
`
`2
`3a
`
`Sa
`Sb
`5c
`7a"
`7b"
`
`7c"
`8a
`
`8b
`8c
`
`150.1 163.4 111.4 134.8 12.3
`150.4 163.9 111.3 134.8 12.2
`
`150.5 164.0 111.1 136.8 12.6
`150.0 162.3 111.3 137.0 12.7
`150.3 163.6 111.2 136.7 12.7
`150.4 164.0 109.4 135.9 12.5
`150.7 163.7 109.5 135.9 12.2
`
`150.4 163.6 109.4 135.9 12.2
`150.6 164.2 111.2 136.9 12.5
`
`150.3 164.2 111.2 136.8 12.6
`150.3 163.3 111.2 136.8 12.6
`
`85.3 37.8 78.0 82.3 64.2 166.2 (C=O), 139.5-134.6 (arom.), 74.1 (OCH 2S), 13.9 (SCH 3 )
`85.0 38.4 76.4 82.5 64.0 166.0 (C---0), 134.8-128.6 (arom), 94.6 (OCH,0),
`68.4, 33.8, 32.6, 29.3, 27.8, 25.3 (6 x CH,)
`86.4 38.1 76.6 85.3 62.4 94.8 (OCH 20), 68.4, 51.4, 36.6, 35.9, 33.7, 32.9 (6 x CH 2 )
`76.7 85.2 62.6 94.9 (OCH 20), 68.6, 51.7, 24.0-20.5 (8 x CH 2)
`86.7 38.1
`86.6 38.1 76.6 85.3 62.6 94.9 (OCH 20), 68.7, 51.6, 29.7-26.3 (10 x CH 2)
`85.0 36.8 76.3 83.5 61.2 93.5 (OCH 20), 67.3, 41.5, 33.2, 29.1, 26.2, 25.6 (6 x CH 2)
`85.0 36.9 76.4 83.8 61.3 93.6 (OCH 20), 67.4, 41.6, 33.2, 29.1, 28.9, 28.8, 26.4, 25.6
`(8 x CH,)
`85.0 36.9 76.4 83.8 61.2 93.6 (OCH 20), 67.3, 41.3, 32.9, 28.9-25.6 (10 x CH 2 )
`86.4 38.2 77.2c 85.4 62.4 157.6 (C---0), 94.8 (OCH 20), 68.3, 39.9, 29.4, 28.8, 26.3, 25.7
`(6 x CH,)
`86.6 38.0 77.2' 85.4 62.5 157.6 (C-0), 94.8 (OCH 20), 68.4, 40.0, 29.5-26.4 (8 x CH 2 )
`86.6 38.0 77 .2 C 85.3 62.5 157.6
`(C=O), 94.8
`(OCH 20), 68.6, 40.0. 29.6---26.6
`(10 x CH,)
`
`• In CDC13 ; ppm from internal tetramethylsilane. • In [ 2H 6]DMSO.' Partial overlapping with the solvent signal.
`
`H2') and 1.67 (3 H, s, 5-CH 3) (Found: C, 56.0; H, 5.4; N, 6.8.
`C 19H 22N 2O 6S 1 requires: C, 56.2; H, 5.46; N, 6.90%).
`
`3a-
`3' -0-( w-Bromoalkoxymethyl)-5' -O-benzoylthymidines
`c. -Compound 2 (2.0 g, 5.0 mmol) was dissolved in dry 1,2-
`dichloroethane (25 cm 3) and NBS (I.I equiv., 1.0 g) or Br2 (282
`mm 3 ) was added to it. After 10 min the appropriate bromo
`alcohol (1.5 equiv.; 6-10 carbons) and lutidine (1.2 cm 3) were
`added. The mixture was stirred overnight at room temperature.
`The reaction was quenched by addition of aq. NaHSO 3 (20
`cm 3). The organic layer was separated, dried over Na2SO4 and
`then concentrated. The oil obtained was normally used for the
`next reaction without further purification. In one case the oil
`was purified on a silica gel column eluting with CH 2Cl 2
`containing from 0 to 3.5% MeOH to give the title compound
`3a; Rr 0.37 (silica gel, CH2Cl 2-MeOH, 97: 3, v /v); Amax(cid:173)
`(MeOH)/nm 266; ..5tt(CDCl3 ) 9.73 (l H, s, H3), 8.03-7.47 (5 H,
`arom), 7.24 (I H, s, H6), 6.32 (l H, dd,J1 ,, 2 , 6.811 _2 .. 6.4, HI'),
`4.76 (2 H, s, OCH 2O), 4.66 (1 H, m, 1 4 ,. 5, 3.8, 1 5 ,. 5 ,, 12.0, H5'),
`4.55 (1 H, m, 14 -y- 4.8, HS'), 4.44 (l H, m, H3'), 4.35 (I H. m,
`H4'), 3.56 (2 H, m, OCH 2 ), 3.39 (2 H, t, l 6.8, CH 2Br), 2.52 (1
`H, m, 1 2 •• 2 ,, 14.2, H2"), 2.17 (1 H, m, 1 2 .. , 3 , 2.8, 1 2 ,, 3 , 5.1, H2'),
`1.83 (2 H, m, OCH2CH2 ), 1.66 (3 H, s, 5CH 3 ), 1.59 (2 H, m,
`CH2CH2Br), 1.44 (2 H, m, OCH 2CH2CH2 ) and 1.38 (2 H, m,
`CH2CH 2CH 2Br).
`
`3' -0-( w-Azidoalkoxymethyl)-5' -O-benzoylthymidines 4a--c.(cid:173)
`LiCI (0.33 g, 7.8 mmol) and NaN3 (1.66 g, 25.5 mmol) were
`suspended in DMF (25 cm3). The mixture was kept at 120 °C
`for 30 min and then allowed to cool to 90 °C. NH 4Cl (0.56 g)
`was added and the whole mixture was poured onto crude 3a--c
`(5 mmol). The suspension was stirred at 50 °C overnight, i.e.
`until HPLC analysis showed that all the starting material was
`consumed, cooled and concentrated under reduced pressure.
`The residue was suspended in methylene chloride (50 cm3) and
`washed with water (50 cm3). The organic layer was dried over
`Na 2SO4 , filtered and then concentrated. The resulting oil was
`dissolved in a small amount of methylene chloride and added
`dropwise into a mixture of diethyl ether-hexane (1: 3, v/v, 250
`cm 3) to remove lutidine and unchanged long chain alcohol. The
`solution was allowed to precipitate and was then decanted. The
`remaining oil was purified by silica gel column chromatography.
`Elution with 0 to 4% MeOH in CH 2Cl 2 gave the title
`compounds 4a--c as colourless oils. 4a: (1.60 g, 57% from 2) Rr
`0.37 (silica gel, CH 2Cl2-MeOH, 97: 3, v/v); AmaiMeOH)/nm
`268; 611(CDCl 3) 8.20 (I H, br, H3), 8.04-7.46 (5 H, arom.), 7.23
`(1 H, s, H6), 6.30 (I H, dd,11 ,, 2 , 7.2,11 .. 2 6.5, HI'), 4.75 (2 H, s,
`
`OCH 2O); 4.66 (1 H, dd, 1 5 ._ 5 .. 12.0, H5'), 4.54 (I H, dd, H5"),
`4.42 (I H, m, H3'), 4.34 (1 H, m, H4'), 3.54 (2 H, m, OCH 2), 3.25
`(2H, t,16.8, CH 2N 3),2.51 (l H,m,12 .z" 13.8, H2"),2.15(1 H,m,
`H2'), 1.66 (3 H, s, 5-CH3), 1.60 (4 H, m, 2 x CH 2) and 1.43 (4 H,
`m, 2 x CH 2 ). 4b: (1.20 g, 45% from 2) Rr 0.39 (silica gel,
`CH 2Cl,-MeOH, 97:3, v/v); Ama.(MeOH)/nm 269;
`..5tt(cid:173)
`(CDCl3) 8.23 (1 H, br s, H3), 8.03-7.47 (5 H, arom), 7.23 (1 H, s,
`H6),6.30(l H,dd,Jl',2' 7.3,Jl',2"6.4,Hl '),4.75(2H, s, OCH2O),
`4.67 (1 H, dd, 14 -, 5 , 2.9, l 5 ._ 5 ,. 12.2, H5'), 4.54 (l H, dd, 14 ,, 5 ,. 3.9,
`H5"), 4.43 (I H, m, H3'), 4.35 (l H, m, H4'), 3.55 (2 H, m,
`OCH 2 ), 3.25 (2 H, t, l 6.8, CH 2N 3), 2.52 (1 H, m, 1 2 ,_ 2 ,. 13.7,
`1 2 ,., 3 , 2.9, H2"), 2.15 (I H, m, 1 2 ,, 3 , 6.8, H2'), 1.66 (3 H, s, 5-
`CH3) and 1.60--1.31 (12 H, m, 6 x CH 2). 4c: (1.28 g, 40% from
`2) Rr 0.40 (silica gel, CH 2Cl 2-MeOH, 97: 3, v/v); Am • .(MeOH)/
`nm 269; ..5tt(CDCl 3) 8.20 (I H, br s, H3), 8.04-7.47 (5 H,
`arom), 7.20 (I H, s, H6), 6.30 (I H, dd, 1 1 ., 2 . 7.3, 1 1 ,, 2 .. 6.3,
`HI'), 4.75 (2 H, s, OCH 2O), 4.66 (1 H, dd, 1 5 ,_ 5 ,. 12.1, H5'), 4.45
`(I H, dd, H5"), 4.37 (l H, m, H3'), 4.37 (1 H, m, H4'), 3.57 (2 H,
`m, OCH 2), 3.25 (2 H, t, l 6.8, CH 2N 3), 2.54 (1 H, m, 1 2 ._ 2 ,. 13.6,
`H2"), 2.15 (1 H, m, H2'), 1.69 (3 H, s, 5-CH 3) and 1.62-1.27 (I 6
`H, m, 8 x CH 2).
`
`3' -O-(ro-Azidoalkoxymethyl)thymidines 5a--c.-Compound
`4a--c was dissolved in sat. methanolic ammonia and stirred
`overnight at room temperature. When the reaction was
`complete, solvent was evaporated under reduced pressure and
`the residue was purified on a silica gel column eluting with
`CH 2Cl2 containing from Oto 5% MeOH. The title compounds
`5a--c were obtained as colourless oils (95% yield). 5a: Rr 0.52
`(silica gel, CH 2Cl2-MeOH, 9:1, v/v); Amax(MeOH)/nm 267;
`..5tt(CDC1 3 ) 9.30 (1 H, br s, H3), 7.43 (I H, s, H6), 6.18 (1 H, dd,
`1 1-. 2 , 7.0,1 1,. 2 ,6.7, Hl'),4.73(2H,s, OCH 2O),4.43(1 H,m,H3'),
`4.07 (1 H, m, H4'), 3.94 (I H, dd, h.s· 2.7,J5 ._ 5 ,. 11.9, H5'), 3.81
`(I H,dd,14.5 3.1, H5"),3.55(2H, t,16.7, OCH 2),3.27(2H, t,J
`6.7, CH 2N 3 ), 2.96(1 H, br 5'-OH), 2.36(2 H, m, H-2', H2"), 1.94
`(3 H, s, 5-CH 3), 1.60 (4 H, m, 2 x CH 2 ) and 1.40 (4 H, m,
`2 X CH2); Vmax/cm- 1 2096s (N3). 5b: Rr 0.54 (silica gel,
`v/v); Am • .(MeOH)/nm 267;
`Jtt(cid:173)
`CH 2Cl,-MeOH, 9: 1,
`(CDCl3)8.30(1 H, brs, H3), 7.38(1 H,s, H6), 6.15(1 H,dd,11 .,2,.
`6.8, HI'), 4. 73 (2 H, s, OCH 2O), 4.43 ( I H, m, H3'), 4.08 ( 1 H, m,
`H4'),3.95(1 H,dd,15 ., 5 ,. 11.8, H5'),3.80(1 H,dd,H5"),3.54(2H,
`t,J 6.8, OCH2 ), 3.28 (2 H, t,J 6.8, CH2N 3), 2.96 (l H, br, 5' -OH),
`2.36 (2 H, m, H2', H2"), 1.92 (3 H, s, 5-CH 3 ) and 1.61-1.33 (12 H,
`m, 6 X CH2); Vmax/cm- 1 2096s (N 3), 5c: Rr 0.56 (silica gel,
`CH 2Cl 2-MeOH, 9:1, v/v); lma/MeOH)/nm 267; ..5tt(CDCl3)
`8.40(1 H, br s, H3), 7.38 (l H, s, H6), 6.16 (1 H, dd,11 ,, 2 , 7.0,11 ,,2 ,.
`6.8, H 1 '), 4. 73 (2 H, s, OCH2O), 4.41 (1 H, m, H3'), 4.07 (I H, m,
`
`

`

`J. CHEM. SOC. PERKIN TRANS. I 1994
`
`H4'),3.94(1 H,dd,15 ., 5 .. l l.9,H5'),3.81 (1 H,dd,H5"),3.54(2H,
`t, 16.8, OCH 2), 3.26 (2 H, t, 16.8, CH2N 3), 2.90 (1 H, hr, 5' -OH),
`2.36 (2 H, m, H2', H2H), 1.92 (3 H, s, 5-CH3) and 1.64-1.29 (16 H,
`m, 8 X CH2); Vmax/cm-1 2096 (N3).
`
`3'-0-(ro-Aminoa/koxymethyl)thymidines 7a-c.-Compound
`Sa (1.12 g, 2.4 mmol) was dissolved in pyridine (30 cm3) and
`Ph3P (2 equiv., 4.0 mmol, 1.05 g) was added. The mixture was
`stirred at room temperature until no starting material could be
`detected by TLC. The resulting ylide was hydrolysed with aq.
`ammonia, evaporated to dryness under reduced pressure,
`suspended in water (50 cm3) and then extracted with diethyl
`ether (3 x 25 cm3). The aqueous layer was evaporated to
`dryness to give compound 7a as a white solid (0.93 g, 93%), Rr
`0.0 (silica gel, CH2Cl2-MeOH 9:1, v/v). The test for primary
`amines was positive.*
`lmaxCH 2O)/nm 267;
`JH([2H 6](cid:173)
`DMSO) 7.70(1 H, s, H6), 6.12(1 H, dd,J1 •• 2• 7.8,11 ., 2 .. 5.9, HI'),
`4.68 (2 H, s, OCH 2O), 4.29 (1 H, m, H3'), 3.91 (l H, m, H4'), 3.61
`(1 H,m,J 4 -, 5-3.9,J5., 5 .. 12.2,H5'),3.56(1 H,m,J4 ., 5 .. 3.9,H5"),3.47
`(2 H, t, J 6.4, OCH2), 2.50 (2 H, m, CH2NH 2 partially
`overlapping with the solvent signal; 2.23 (1 H, m,J2 .,2 .. 13.2, 1 2 .. ,3 ,
`3.6, H2"), 2.14 (1 H, m, 1 2 ,, 3 , 6.2, H2'), 1.77 (3 H, s, 5-CH 3) and
`1.50-1.29 (8 H, m, 4 x CH 2). With the analogues bearing a
`longer aliphatic arm (8 and 10 carbons) at 03' the product (7b
`and c) was not soluble enough in water to be extracted as
`described. Accordingly, after hydrolysis and the first evapor(cid:173)
`ation, the remaining triphenylphosphine was removed by
`stirring the solid material with diethyl ether. The ethereal layer
`was carefully decanted and the remaining solid material was
`dried under reduced pressure. HPLC analysis showed that 7b
`was homogenous, but 7c contained 10% of impurities. 7b: Rr
`0.0 (silica gel, CH2Cl2-MeOH, 9: 1, v/v). The test for primary
`amines was positive. A.maxCMeOH)/nm 266; t58 ([2H 6]DMSO)
`7.70 (l H, s, H6), 6.12 (1 H, dd, J 1., 2, 7.8, 1 1 ., 2 .. 5.9, HI'), 4.68
`(2 H, s, OCH 2O), 4.29 (I H, m, H3'), 3.90 (l H, m, H4'), 3.61 (I
`H, m, 14 ,. 5 .. 3.9, 1 5 •• 5 .. 12.2, H5'), 3.56 (1 H, m, 14 ,_ 5 .. 3.9, H5"),
`3.47 (2 H, t, 1 6.8, OCH 2 ), 2.50 (2 H, m, CH2NH 2 , partially
`overlapping with the solvent signal), 2.24 (I H, m, 12 •• 2 .. 13.7,
`J 2 ... 3, 2.4, H2"), 2.15 (1 H, m, J 2 ,, 3 • < 1, H2'), 1.77 (3 H, s, 5-
`CH3) and 1.50-1.25 (12 H, m, 6 x CH2 ). 7c: Rr 0.0 (silica gel,
`CH 2Cl 2-MeOH, 9:1, v/v). The test for primary amines was
`positive. Amax(MeOH)/nm 266; t5tt([2H 6]DMSO) 7.70 (1 H, s,
`H6), 6.13 (I H, dd, 1 1,.2 , 7.8, 1 1,_ 2 .. 6.0, HI'), 4.68 (2 H, s,
`OCH 2O), 4.29 (1 H, m, H3'), 3.91 (l H, m, H4'), 3.61 (I H, m,
`J 5., 5 .. 12.2, H5'), 3.56 (I H, m, H5"), 3.46 (2 H, t, 16.8, OCH2),
`2.50 (2 H, m, CH2NH 2, partially overlapping with the signal of
`solvent), 2.22 (2 H, m, H2', H2"), 1. 77 (3 H, s, 5-CH3) and
`l.50-1.29 (16 H, m, 8 x CH 2).
`
`3 '-0-(N-Trifluoroacetyl-ro-aminoa/koxymethyl)thymidines
`8a-c.-Compound 7a-c (1.0 mmol) was dissolved in dry DMF
`(2.5 cm3) freshly distilled methyl trifluoroacetate (l.3 cm 3) was
`added. The reaction mixture was stirred overnight at room
`temperature. Solvent and the unchanged ester were evaporated
`under reduced pressure and the resulting oil was purified on a
`silica gel column eluting with 3% MeOH in CH2Cl 2 • The title
`compounds 8a-c were obtained as colourless oils. Sa: (0.44 g,
`95%); Amax(MeOH)/nm 266; JH(CDCl 3) 9.48 (1 H, hr s, H3),
`7.51 (] H,s, H6), 7.09(1 H, brt, NHCOCF3),6.18(1 H,dd,J1 •• 2 •
`6.8, 1 1, •2 .. 6.8, HI'), 4. 73 (2 H, s, OCH2O); 4.44 (l H, m, H3'), 4.09
`(1 H,m, H4'), 3.93(1 H,m,J5 ,. 5 .. 10, HS'), 3.81 (l H,m, H5"), 3.55
`(2 H, t,16.8, OCH 2), 3.36(2 H, q, J6.8, CH2NHCOCF3), 3.26
`(1 H, hr, 5'-OH); 2.39 (1 H, ddd,J2 •• 2 .. 13.7,12 ... 3 . 3.7, H2"), 2.31
`(I H, m, 12 ._3. 6.8, H2'), l.89 (3 H, s, 5-CH3), 1.60 (4 H, m,
`
`• 'Fluram', Roche Spray Reagent for assay of primary amines, F.
`Hoffman-La Roche Co. Limited, Diacnostica, Basie, Switzerland.
`
`215
`
`2 x CH2) and 1.38 (4 H, m, 2 x CH2) (Found: C, 49.2; H, 6.2;
`N, 8.8. C 19H 28F 3N 3O 7 requiresC,48.82; H, 6.04; N, 8.99%). Sb:
`(0.44 g, 90%); ,l,m0,.(MeOH)/nm 266; dtt(CDCl3) 8.94 (1 H,
`hrs, H3), 7.44 (I H, s, H6), 6.67 (1 H, br t, NHCOCF 3), 6.16 (1
`H, dd, 1 1 ,,2 • 6.8, 1 1 .,2 .. 6.8, HI'), 4.73 (2 H, s, OCH 2O), 4.42 (I
`H, m, H3'), 4.08 (1 H, m, H4'), 3.93 (1 H, m, 15 .,5 .. 12.0, H5'),
`3.81 (l H, m, HS"), 3.55 (2 H, t, 16.8, OCH2), 3.36(2 H, q,16.8,
`CH2NHCOCF 3), 2.85 (1 H, hr, 5'-OH), 2.36 (2 H, m, H2',
`H2"), 1.89 (3 H, s, 5-CH 3) and 1.58-1.33 (12 H, m, 6 x CH 2)
`(Found: C, 50.95; H, 6.4; N, 8.4. C 21 H 32F 3N 3O 7 requires C,
`50.90; H, 6.51; N, 8.48%). Sc: (0.46 g, 87%); J.maxCMeOH)/nm
`268;t58 (CDC13) 8.63 (1 H, hrs, H3), 7.41 (l H, s, H6), 6.48 (1 H,
`brt, NHCOCF3 ), 6.16(1 H, dd,11,, 2 , 6.8, 1 1 ,,2 .. 6.8, HI'), 4.73(2
`H, s, OCH2O), 4.42 (1 H, m, H3'), 4.08 (1 H, m, H4'), 3.94 (1 H,
`m, J 5 ., 5 .. 10.0, H5'), 3.81 (l H, m, H5"), 3.54 (2 H, t, 1 6.8,
`OCH 2), 3.36 (2 H, q, 16.8, CH2NHCOCF3), 2.64 (1 H, hr, 5'(cid:173)
`OH), 2.37 (2 H, m, H2', H2"), 1.89 (3 H, s, 5-CH 3) and 1.29 (16
`(Found: C, 52.7; H, 6.8; N, 8.0.
`H, m, 8 x CH2)
`C 23H 36F 3N 3O 7 requires C, 52.77; H, 6.93; N, 8.03%).
`
`3' -0-(N-Trifluoroacetyl-ro-aminoalkoxymethyl)thymidine 5' -
`Triphosphates 9a-c as Triethylammonium Salts.-Dry, recrys(cid:173)
`tallized triazole (4.5 equiv. to nucleoside, 31 mg, 0.45 mmol) was
`dissolved in a mixture of dry acetonitrile (0.5 cm3) and dry
`triethylamine (4.5 equiv., 63 mm3). The mixture was cooled on
`an ice bath and phosphorus oxychloride (1.5 equiv, 14 mm3)
`was added. The mixture was allowed to warm to room
`temperature and stirred for 30 min. The whole mixture was
`quickly filtered and the filtrate was poured on dried nucleoside
`Sa~ (0.1 mmol) and stirred at room temperature until all
`starting material had disappeared (normally 10 to 20 min).
`Then bis(butylammonium)pyrophosphate in DMF (0.2 mo!
`dm-3 ; 1.5 equiv., 2.5 cm3) was added and the reaction was
`stirred overnight at room temperature. The remaining triazole
`ligand was hydrolysed by water (5 cm3). The reaction mixture
`was diluted with water (100 cm 3) containing 50% (v/v)
`acetonitrile. The crude material was applied onto an ion
`exchange column and eluted with a linear gradient [0.0-0.3
`mol dm-3 TEAB (triethylammonium hydrogen carbonate) in
`50%, v/v, MeCN]. The fraction eluted at 0.2 mo! dm-3 TEAB
`was collected and concentrated. The oily residue was further
`purified on a preparative RP-18 column (Reliasil 300 A, 5 µm,
`250 mm x 9 mm) and eluted with water containing 40% (v/v)
`acetonitrile. 9a: JH(D 2O) 7.59 (1 H, s, H6), 6.15 (1 H, dd, 1 1 ,. 2 ,
`8.2, 1 1 •• 2 .. 6.0, HI'), 4.69 (2 H, s, OCH2O, partial overlapping
`with the signal of solvent), 4.40 (1 H, m, H3'), 4.17 (l H, m,
`H4'), 4.05 (2 H, m, H5', H5"), 3.49 (2 H, m, OCH 2), 3.14 (2 H, t,
`16.8, CH2NHCOCF3), 2.31 (I H, m, J2 ,, 2 .. 14.0, H2"), 2.21 (1
`H, m, H2'), 1.76 (3 H, s, 5-CH3) and 1.43-1.30 (8 H, m,
`4 x CH 2). 9b:t58 (D2O)7.60(1 H,s, H6), 6.15 (l H, d,J1 •• 2 , 6.0,
`HI'), 4. 70 (2 H, s, OCH 2O, partial overlapping with the solvent
`signal), 4.42 (l H, m, H3'), 4.15 (1 H, m, H4'), 4.07 (2 H, m, H5',
`H5"), 3.50(2 H,m, OCH2), 3.17 (2H, t,16.8, CH2NHCOCF3),
`2.31 (1 H, m, 1 2 •• 2 .. 14, H2"), 2.21 (1 H, m, H2'), 1.77 (3 H, s, 5-
`CH3) and 1.41-1.29 (12 H, m, 6 x CH 2). 9c: JH(D2O) 7.61 (1
`H, s, H6), 6.17 (l H, dd, 1 1 ,,2 .. 8.3, HI'), 4.70 (2 H, s, OCH2O,
`partial overlapping with the solvent signal), 4.41 (1 H, m, H3'),
`4.18 (l H, m, H4'), 4.06 (2 H, m, H5', H5"), 3.46 (2 H, m,
`OCH2 ), 3.15 (2H, t,J6.8, CH2NHCOCF3 ), 2.32(1 H, m,12 ,,2 ..
`14.3, H2"), 2.22 (1 H, m, H2'), 1.77 (3 H, s, 5-CH 3), 1.44 (4 H,
`m, 2 x CH2) and 1.15 (16 H, m, 8 x CH2). All 1H NMR
`spectra also exhibited signals from the triethylammonium
`group (q 3.03 and t 1.13), which disturbed integration.
`
`5' -Triphosphates
`3 '-O-( ro-Aminoa/koxymethyl)thymidine
`lOa-c.-Compounds 9a--c were dissolved in aq. ammonia,
`stirred overnight at room temperature and then evaporated to
`dryness under reduced pressure to give the title compounds.
`
`

`

`216
`
`J. CHEM. SOC. PERKIN TRANS. I 1994
`
`Table 2 Properties of 3'-O-modified thymidine 5'-triphosphates prepared
`
`31 P NMR chemical shifts'
`
`Compound
`
`la/min"
`
`tR/min b
`
`9a
`9b
`9c
`IOa
`IOb
`IOc
`
`24.2
`24.6
`25.0
`22.1
`22.5
`23.0
`
`23.7
`26.7
`32.9
`14.6
`17.1
`22.3
`
`/,ffil:IX
`
`267
`268
`270
`268
`269
`267
`
`A.min
`
`235
`234
`235
`235
`233
`234
`
`o[P(IX)]
`
`o[P(~)]
`
`o[P(y)]
`
`-11.71
`-11.65
`-11.59
`-8.39
`-8.36
`-8.34
`
`-23.96
`-23.95
`-23.91
`-23.46
`-23.44
`-23.43
`
`- 12.34
`-12.32
`-12.17
`-12.23
`-12.19
`-12.18
`
`• Ion exchangecotumn (SynchropakAX-300, 6.5 µm,4.6 x 250 mm), flow rate 1.0 cm 3 min- 1 , A = 0.03 motdm-3 KH 2 PO4 , 50%formamide(pH =
`5.2), B = 0.03 mot dm-3 KH 2PO4 , 1.0 mol drn 3 (NH 4 ),SO4 , 50% formamide (pH = 5.6), from A to B in 30 min. b Reversed-phase column
`(Nucleosil 300-5 C4, 5 µm, 250 mm x 9 mm; Macherey-Nagel, A = 0.05 mot dm- 1 TEAA, pH 5.5; B = A + 50% MeCN, from 40 to 70% Bin 45
`min, flow rate 0.8 cm 3 min- 1).' In D 2O, external reference H 3PO4 (0.00 ppm). Assignments of P(ix) and P(y) are tentative.
`
`Purification was performed on reversed-phase HPLC as
`described above for 9a-c. IOa: oH(D2O) 7.61 (I H, s, H6), 6.17
`(1 H, dd, J 1 •.i· 6.8, J 1 ,_ 2 .. 5.4, HI'), 4.70 (2 H, s, OCH 2O, partial
`overlapping with the solvent signal), 4.40 (l H, m, H3'), 4.24 (I
`H, m, H4'), 4.05 (2 H, m, H5', HS"), 3.45 (2 H, m, OCH 2), 2.88
`(2 H, t, CH2NH2), 2.32 (I H, m, H2"), 2.21 (I H, m, H2'), 1.68
`(3 H, s, 5-CH 3) and 1.50-1.25 (8 H, m, 4 x CH 2). 10b: oH(D 2O)
`7.61 (I H, s, H6), 6.17 (I H, dd,Jl ',2" 6.8J1·.2" 5.9, HI'), 4.70 (2
`H, s, OCH 2O, partial overlapping with the solvent signal), 4.41
`(I H, m, H3'), 4.18 (1 H, m, H4'), 4.06 (2 H, m, H5', H5''), 3.46
`(2 H, m, OCH2), 2.88 (2 H, t, CH2NH 2 ), 2.32 (I H, m, H2"),
`2.23 (1 H, m, H2'}, 1.79 (3 H, s, 5-CH 3) and 1.45-1.15 (12 H, m,
`6 x CH 2 ). toe: oH(D 2O) 7.61 (I H, s, H6), 6.19 (I H, dd, 1 1 ,, 2 ,
`6.7, J 1 .,2 .. 5.7, HI'), 4.70 (2 H, s, OCH2O, partial overlapping
`with the solvent signal), 4.41 (I H, m, H3'), 4.18 (I H, m, H4'),
`4.06 (2 H, m, H5', H5"), 3.46 (2 H, m, OCH 2 ), 2.89 (2 H, t,
`CH2NH 2), 2.32 (I H, m, H2"), 2.22 ( I H, m, H2'), 1.77 (3 H, s,
`5-CH 3 ) and 1.45-1.29 (16 H, m, 8 x CH 2 ); Table 2 records the
`HPLC retention times, UV absorption maxima and 31 P NMR
`shifts of 9a-c and lOa-c.
`
`Labelling of CompoundlOa with Fluorescein Isothiocyanate.-(cid:173)
`Compound 10a (10 OD) (OD= optical density unit) was
`dissolved in carbonate buffer (0.1 mo! dm-3 ; 2.5 cm3, pH =
`10.3). Fluorescein isothiocyanate (50 mg) in DMF (2.5 cm3 )
`was added and the pH was readjusted to 10 with NaOH (0.1
`mo! dm-3 ). The mixture was kept overnight in the dark at room
`temperature. The pH was adjusted to 3 with HCI (1.0 mol
`dm 3), after which the mixture was extracted with ethyl acetate
`(4 x 10 cm 3). The organic layer was discarded and the aqueous
`layer was neutralized with sat. NaHCO 3 . NaHCO 3 • The crude
`product was purified by ion exchange HPLC [Synchropak AX-
`300, 6.5 µm, 4.6 x 250 mm; A = 0.05 mol dm- 3 KH 2 PO4 , 50%
`formamide, pH 5.2; B = 0.05 mo! dm- 3 K

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket